Connect with us

Cannabis News

Abundance Of Cannabis Study Requests Leave Researchers “Swamped” In Canada

Published

on

Abundance-of-Cannabis-Study-Requests-Leave-Researchers-Swamped
  • Canada legalized recreational and medical use of cannabis in October 2018.
  • Presently, authorities have approved 113 licenses for permits involving cannabis.

Canada chose to legalize both recreational and medicinal marijuana in October last year, and the applications for licenses flooded the government as applicants hoped to be involved as the market began. As of the end of July, there were over 250 applicants waiting to hear back, but the wait times are months long. The impacted parties from these delays aren’t just the dispensaries and the consumers, but scientists that are looking to research the substance. These delays aren’t boding well with anyone, especially Health Canada, which is the agency tasked with issuing the permits.

Jonathan Page, the chief science officer for licensed producer Aurora Cannabis, said, “Everybody is growing, consuming, and buying it, but the labs are still: ‘How do we get these projects going?’ The [licensing] system is swamped, and research is not exactly, I think, a priority.”

Health Canada has commented that they’ve been trying to speed up the process of approvals, especially for scientists, but this process is “incredibly slow – much slower than it used to be,” says Igor Kovalchuk. Kovalchukis is a plant geneticist, working at the University of Lethbridge, leading him to research cannabis when the substance was still considered a narcotic. However, as soon as the country legalized recreational use, “things slowed down tremendously.”

As soon as legalization happened, new applications for licenses to research, produce, distribute, and sell cannabis boomed. These applicants had to submit plans for their locations with proper security features, the quantities they planned to receive or grow, and even state how the leftover cannabis would be disposed of at the end of research projects.

Applications are presently being processed as fast as they can, and Health Canada has even increased their staff to 140 employees. As news organization CTV revealed how long the wait would be, the agency has even started releasing weekly announcements regarding how many permits had been granted.

As of August 16th, the total permits provided by Health Canada had only reached 113 approvals. However, the agency has established a new goal of a 42-day turnaround time for research licenses, which will hopefully speed up their work.

Andrew is a full-time professional writer in Canada with over 8 years of esteemed experience. He is one of the best cannabis health researchers, polished legal investigators and active CBD news reporters we have at TOC. While being featured in hundreds of health, technology, science, and even bitcoin publications; Andrew's now on the frontline of the Canadian cannabis culture and will continue breaking down everything so easily your grandma can understand hemp and CBD.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.